Benzodiazepines: Risks and benefits. A reconsideration
Benzodiazepines: Risks and benefits. A reconsideration
Over the last decade there have been further developments in our knowledge of the risks and benefits of benzodiazepines, and of the risks and benefits of alternatives to benzodiazepines. Representatives drawn from the Psychopharmacology Special Interest Group of the Royal College of Psychiatrists and the British Association for Psychopharmacology together examined these developments, and have provided this joint statement with recommendations
for clinical practice. The working group was mindful of widespread concerns about benzodiazepines and related anxiolytic and hypnotic drugs. The group believes that whenever benzodiazepines are prescribed, the potential for dependence or other harmful effects must be considered. However, the group also believes that the risks of dependence associated with long-term use should be balanced against the benefits that in many cases follow from the short or intermittent use of benzodiazepines and the risk of the underlying conditions for which treatment is being provided.
967-971
Baldwin, D.S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Aitchison, K.
11d39f87-e90c-4924-9fab-d03560e2739a
Bateson, A.
f32ee4cf-9c4c-4133-ba48-a695ff75916c
Curran, H.V.
25f147ef-f161-469a-b279-bac3005bd919
Davies, S.
5b030b81-3805-489a-bb2a-96d9dff61b07
Leonard, B.
a0c052ae-c162-4dd7-b143-49403d3b25a0
Nutt, D.J.
69e892da-bec7-415f-aaed-c414b1e764fd
Stephens, D.N.
6bfff0d3-40d5-4236-9e34-58e0402ed321
Wilson, S.
95286d3e-048c-44a0-ad36-2897805b385a
November 2013
Baldwin, D.S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Aitchison, K.
11d39f87-e90c-4924-9fab-d03560e2739a
Bateson, A.
f32ee4cf-9c4c-4133-ba48-a695ff75916c
Curran, H.V.
25f147ef-f161-469a-b279-bac3005bd919
Davies, S.
5b030b81-3805-489a-bb2a-96d9dff61b07
Leonard, B.
a0c052ae-c162-4dd7-b143-49403d3b25a0
Nutt, D.J.
69e892da-bec7-415f-aaed-c414b1e764fd
Stephens, D.N.
6bfff0d3-40d5-4236-9e34-58e0402ed321
Wilson, S.
95286d3e-048c-44a0-ad36-2897805b385a
Baldwin, D.S., Aitchison, K., Bateson, A., Curran, H.V., Davies, S., Leonard, B., Nutt, D.J., Stephens, D.N. and Wilson, S.
(2013)
Benzodiazepines: Risks and benefits. A reconsideration.
Journal of Psychopharmacology, 27 (11), .
(doi:10.1177/0269881113503509).
Abstract
Over the last decade there have been further developments in our knowledge of the risks and benefits of benzodiazepines, and of the risks and benefits of alternatives to benzodiazepines. Representatives drawn from the Psychopharmacology Special Interest Group of the Royal College of Psychiatrists and the British Association for Psychopharmacology together examined these developments, and have provided this joint statement with recommendations
for clinical practice. The working group was mindful of widespread concerns about benzodiazepines and related anxiolytic and hypnotic drugs. The group believes that whenever benzodiazepines are prescribed, the potential for dependence or other harmful effects must be considered. However, the group also believes that the risks of dependence associated with long-term use should be balanced against the benefits that in many cases follow from the short or intermittent use of benzodiazepines and the risk of the underlying conditions for which treatment is being provided.
Text
Benzodiazepines_Guidelines_2013[1].pdf
- Other
Restricted to Repository staff only
Request a copy
More information
Published date: November 2013
Organisations:
Faculty of Medicine
Identifiers
Local EPrints ID: 367922
URI: http://eprints.soton.ac.uk/id/eprint/367922
ISSN: 0269-8811
PURE UUID: b490e117-3819-4ee7-88ed-4c8f6e9b7e96
Catalogue record
Date deposited: 21 Aug 2014 09:07
Last modified: 15 Mar 2024 02:49
Export record
Altmetrics
Contributors
Author:
K. Aitchison
Author:
A. Bateson
Author:
H.V. Curran
Author:
S. Davies
Author:
B. Leonard
Author:
D.J. Nutt
Author:
D.N. Stephens
Author:
S. Wilson
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics